The pharmaceutical giant, Eli Lilly has just launched its newly approved GLP-1 product, Zepbound, in a direct-to-consumer approach on its Lilly Direct
Import Alerts by Publish Date (entry for Import Alert 66-80, published 06/22/2026)
Like road trips, maintaining the right temperature is key, so use insulated bags with cooling pads as needed
Emerging as a promising therapeutic target, hepsin holds potential for combination therapy with N-acetylcysteine, paving the way for novel approaches in managing drug-induced liver injury
Overall, the potential benefits of using 3-D printing for compounded Semaglutide therapy include: More accurate dosing Greater affordability Easier to meet pattern preferences (in terms of color, shape, and size of the tablet) Better medication adherence While no pharmacies are using 3D printing technology to print compounded Semaglutide pills just yet, its an innovation that our assisted living pharmacy believes will find its way into a pharmacists workflow soon